Selected article for: "antibody response and commercial vaccine"

Author: Carabineiro, Sónia Alexandra Correia
Title: Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines †
  • Document date: 2017_5_22
  • ID: 0nz0qioh_62
    Snippet: Synthetic virus-like particles (sVLPs) were prepared by incubating 100 nm gold nanoparticles in a solution containing an avian coronavirus spike protein [127] . After removing the free proteins, antigen-laden particles were recovered and showed morphological semblance to natural viral particles. Vaccination with the sVLPs showed enhanced lymphatic antigen delivery, stronger antibody titers, increased splenic T-cell response, and reduced infection.....
    Document: Synthetic virus-like particles (sVLPs) were prepared by incubating 100 nm gold nanoparticles in a solution containing an avian coronavirus spike protein [127] . After removing the free proteins, antigen-laden particles were recovered and showed morphological semblance to natural viral particles. Vaccination with the sVLPs showed enhanced lymphatic antigen delivery, stronger antibody titers, increased splenic T-cell response, and reduced infection-associated symptoms, and provided superior antiviral protection when compared to a commercial whole inactivated virus vaccine [127] .

    Search related documents:
    Co phrase search for related documents
    • antibody titer and gold nanoparticle: 1
    • antibody titer and inactivated virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • antibody titer and inactivated virus vaccine: 1, 2, 3, 4
    • antibody titer and spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antibody titer and strong antibody titer: 1, 2, 3, 4, 5, 6, 7, 8
    • antigen delivery and avian coronavirus: 1
    • antigen delivery and avian coronavirus spike protein: 1
    • antigen delivery and free protein: 1
    • antigen delivery and gold nanoparticle: 1, 2, 3, 4, 5, 6
    • antigen delivery and inactivated virus: 1, 2, 3, 4, 5
    • antigen delivery and inactivated virus vaccine: 1, 2
    • antigen delivery and lymphatic antigen delivery: 1, 2
    • antigen delivery and morphological semblance: 1
    • antigen delivery and spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • antiviral protection and inactivated virus: 1, 2, 3
    • antiviral protection and inactivated virus vaccine: 1, 2
    • antiviral protection and lymphatic antigen delivery: 1
    • antiviral protection and morphological semblance: 1
    • antiviral protection and spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9